INS and fatty liver disease: In contrast, fat-specific Blnc1 transgenic mice (Blnc1 Tg mice) exhibited much lower plasma insulin concentrations, improved insulin sensitivity and glucose tolerance as well as ameliorated hepatic steatosis.